1. Home
  2. RVMD vs BFAM Comparison

RVMD vs BFAM Comparison

Compare RVMD & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • BFAM
  • Stock Information
  • Founded
  • RVMD 2014
  • BFAM 1986
  • Country
  • RVMD United States
  • BFAM United States
  • Employees
  • RVMD N/A
  • BFAM N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • BFAM Other Consumer Services
  • Sector
  • RVMD Health Care
  • BFAM Consumer Discretionary
  • Exchange
  • RVMD Nasdaq
  • BFAM Nasdaq
  • Market Cap
  • RVMD 7.4B
  • BFAM 7.1B
  • IPO Year
  • RVMD 2020
  • BFAM 1997
  • Fundamental
  • Price
  • RVMD $39.66
  • BFAM $122.37
  • Analyst Decision
  • RVMD Strong Buy
  • BFAM Buy
  • Analyst Count
  • RVMD 12
  • BFAM 8
  • Target Price
  • RVMD $68.67
  • BFAM $139.13
  • AVG Volume (30 Days)
  • RVMD 1.7M
  • BFAM 460.7K
  • Earning Date
  • RVMD 08-06-2025
  • BFAM 07-31-2025
  • Dividend Yield
  • RVMD N/A
  • BFAM N/A
  • EPS Growth
  • RVMD N/A
  • BFAM 93.82
  • EPS
  • RVMD N/A
  • BFAM 2.77
  • Revenue
  • RVMD N/A
  • BFAM $2,728,831,000.00
  • Revenue This Year
  • RVMD N/A
  • BFAM $9.64
  • Revenue Next Year
  • RVMD $241.39
  • BFAM $7.16
  • P/E Ratio
  • RVMD N/A
  • BFAM $43.67
  • Revenue Growth
  • RVMD N/A
  • BFAM 9.71
  • 52 Week Low
  • RVMD $29.17
  • BFAM $100.59
  • 52 Week High
  • RVMD $62.40
  • BFAM $141.90
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 49.08
  • BFAM 42.99
  • Support Level
  • RVMD $38.57
  • BFAM $122.90
  • Resistance Level
  • RVMD $42.40
  • BFAM $125.62
  • Average True Range (ATR)
  • RVMD 1.38
  • BFAM 2.52
  • MACD
  • RVMD -0.16
  • BFAM -0.71
  • Stochastic Oscillator
  • RVMD 28.46
  • BFAM 20.25

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

Share on Social Networks: